June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
The importance of Slc16a8 in light-induced retinal degeneration
Author Affiliations & Notes
  • Bailey Hannon
    Genentech Inc, South San Francisco, California, United States
  • Navid Nouri
    Genentech Inc, South San Francisco, California, United States
  • TOM TRUONG
    Genentech Inc, South San Francisco, California, United States
  • Gyeong Jin Kang
    Genentech Inc, South San Francisco, California, United States
  • Brian Yaspan
    Genentech Inc, South San Francisco, California, United States
  • Heinrich Jasper
    Genentech Inc, South San Francisco, California, United States
  • Shawnta Y Chaney
    Genentech Inc, South San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Bailey Hannon Genentech, Code E (Employment); Navid Nouri Genentech, Code E (Employment); TOM TRUONG Genentech, Code E (Employment); Gyeong Jin Kang Genentech, Code E (Employment); Brian Yaspan Genentech, Code E (Employment); Heinrich Jasper Genentech, Code E (Employment); Shawnta Chaney Genentech, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2470 – F0177. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bailey Hannon, Navid Nouri, TOM TRUONG, Gyeong Jin Kang, Brian Yaspan, Heinrich Jasper, Shawnta Y Chaney; The importance of Slc16a8 in light-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2470 – F0177.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The RPE serves as the blood/retina barrier and facilitates removal of metabolic byproducts from the subretinal space to the choroid. Slc16a8 (Mct3) is an RPE-specific proton coupled monocarboxylate transporter responsible for lactate export identified by human genetic analyses to be associated with age-related macular degeneration (AMD). We investigated the loss of Slc16a8 under constant light exposure (CLE) conditions as a potential stress model, similar to that seen in aging patients, to gain new functional insights into AMD pathobiology.

Methods : Mice with CRISPR mediated deletion of Slc16a8 were used to generate 10-week old Slc16a8-/- (n=6), Slc16a8+/- (n=13), and Slc16a8+/+ (n=8) mice. Full-field ERGs (150 cd*s/m2) were measured at baseline and after CLE to determine photoreceptor, bipolar, and RPE cell function using a-, b-, and c-wave amplitudes. OCT was measured at baseline and after CLE to evaluate retinal thickness. Mice were subjected to a CLE of 100k lux for 7 days to induce retinal degeneration.

Results : At baseline (Fig. 1A), eyes from Slc16a8-/- mice had decreased a-, b-, and c-wave amplitudes compared to Slc16a8+/- and Slc16a8+/+ eyes (all p<0.0001). Eyes from Slc16a8+/- mice had decreased a- (p=0.0002) and c-waves (p=0.01) compared to Slc16a8+/+ eyes. No differences in retinal thickness between genotypes at baseline were found. After CLE, all eyes had decreased a- and b-waves (p<0.0001). Retinas from Slc16a8+/- and Slc16a8+/+ thinned after CLE (p<0.0001), but eyes from Slc16a8-/- slightly thickened (p=0.011). Eyes from Slc16a8+/-, but not Slc16a8-/-, mice showed more loss of a- and c-waves and more retinal thinning compared to eyes from Slc16a8+/+ mice (Fig. 1B, p=0.0002, 0.002, and <0.0001).

Conclusions : Slc16a8 (Mct3) is necessary for retinal function, but does not affect retinal morphology prior to CLE. After CLE, eyes with complete loss of Slc16a8 do not have increased RPE cell dysfunction, but appear to have retinal edema, perhaps due to proton coupled lactate buildup. Mice with partial loss of Slc16a8 are prone to more photoreceptor and RPE cell dysfunction and more retinal thinning after CLE. These results show that Slc16a8 is key for proper retinal function, both before and after the CLE model of stress-induced retinal degeneration.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

A) Baseline ERG and OCT measurements for each genotype. B) Percent change in ERG and OCT measurements from baseline to after CLE. One-way ANOVA, Tukey post-hoc, mean ± SD.

A) Baseline ERG and OCT measurements for each genotype. B) Percent change in ERG and OCT measurements from baseline to after CLE. One-way ANOVA, Tukey post-hoc, mean ± SD.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×